Searched for
PHARMEASY EQUITY
Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...- PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seatsPai is also joining the board of PharmEasy and is expected to work with CEO Shah. He will retain the board seats as long as his holding doe...
- Goldman may convert part-debt into equity in PharmEasyThe online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4
- ETtech Explainer: What are down rounds and will they become the norm for Indian startups?A down round is when a privately held firm raises funds at a valuation lower than that ascribed in the previous round.
- PharmEasy parent seeks shareholder nod to increase authorised share capitalThe board notified its shareholders about increasing the authorised share capital to Rs 3,500 crore (about $423.72 million), divided into 3...
- Global asset manager Janus Henderson cuts PharmEasy valuation further to $2.7 billionAs of March 31, 2023, funds managed by Janus Henderson valued their stake in the startup at $2.7 billion – less than half of the $5.6 billi...
- PharmEasy fails to raise Rs 1,000 crore equity, breaches covenant on Goldman Sachs loanPharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...
- PharmEasy delays IPO, targets Ebitda breakeven by next yearThe Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...
- Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parentThe money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare las...
- Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.
- Thyrocare set for fast track with PharmEasyThyrocare is primarily a B2B diagnostic services provider. With PharmEasy’s presence, it will no longer be seen as a conventional diagnosti...
- ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...
- PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.
- PharmEasy valued at $1.8 billion as B Capital buys stake for $20 millionE-pharmacy conducts $3 million Esop buyback; Tiger Global also putting primary capital in Mumbai-based startup.
- B Capital, Tiger Global eye PharmEasy stakeThe total size of the transaction could be about $40 million and may value the company at about $1.8 billion, up from the current $1.5 bill...
- Prosus in talks to put $200 million into PharmEasyProsus is expected to get a double-digit stake in PharmEasy's parent. Private equity major TPG Capital is also picking up about 7% stake in...
- PharmEasy in investment talks with Naspers, TPGOnline pharmacies such as PharmEasy and 1mg have registered growth outside their core metropolitan markets by rapidly expanding into tier-2...
- Reliance retail acquires majority stake in Netmeds' parent for Rs 620 croreIn a late evening filing, RIL said that it will also get a 100% direct equity ownership of Netmeds' subsidiaries, Tresara Health, Netmeds M...
- PharmEasy is closing in on $120 million in equity roundThe transaction, which is expected to close by the end of the month, will value the five-yearold company at $500-600 million, according to ...
- Pharmeasy raises Rs 40 cr in debtThis is the second such venture debt financing by the company, which had raised Rs 15 crore from Trifecta Capital last year.
Load More
